Impact of hepatic immunoreactivity of angiotensin-converting enzyme 2 on liver fibrosis due to non-alcoholic steatohepatitis


Cengiz M., Ozenirler S., Yilmaz G., Erkan G.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, vol.39, no.6, pp.692-698, 2015 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 39 Issue: 6
  • Publication Date: 2015
  • Doi Number: 10.1016/j.clinre.2015.02.010
  • Title of Journal : CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY
  • Page Numbers: pp.692-698

Abstract

Background: We aimed to evaluate the hepatic immunoreactivity of angiotensin-converting enzyme 2 (ACE2) in non-alcoholic steatohepatitis (NASH) patients, elucidate its association with the clinicopathological characteristics and also determine its role in fibrosis progression.